Skip to main content
Ruby Meredith, MD, Radiation Oncology, Birmingham, AL

RubyFMeredithMDFASTRO

Radiation Oncology Birmingham, AL

Professor of Radiation Oncology, University Alabama

Dr. Meredith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Meredith's full profile

Already have an account?

  • Office

    619 19th St S
    Birmingham, AL 35249
    Phone+1 205-934-5670
    Fax+1 205-975-7039

Summary

  • Research Director

Education & Training

  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1983
  • Other
    OtherClass of 1983

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1987 - 2024
  • VA State Medical License
    VA State Medical License 1984 - 2016
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014, 2020
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • 90y-Zevalin Radioimmunotherapy Using A Modified Treatment Regimen For Relapsed ONational Center For Research Resources2007
  • C225 With Chemoradiation For Post-Op Head And Neck Squamous Cell CancerNational Center For Research Resources2006–2007
  • UAB 9846 Phase I Trial Of 131i-Hucc49dch2 For Colon CancerNational Center For Research Resources2005–2006
  • C225 With Chemoradiation For NsclcNational Center For Research Resources2005–2006
  • Pretargeting Radioimmunotherapy Of Metastatic BreastNational Cancer Institute2000–2002
  • Recombinant Keratinocyte Growth Factor In Head &Neck CancerNational Center For Research Resources1999–2002
  • Interferon Enhanced CC49 Monoclonal Antibody In Metastatic Prostate CancerNational Center For Research Resources1996–1997
  • Intraperitoneal Radioimmunochemotherapy Of CancerNational Cancer Institute1995